The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society
- PMID: 20728695
- DOI: 10.1016/j.pcad.2010.06.002
The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society
Abstract
Cardiac disease in patients with cancer is common and influences the longevity and quality of life both of patients in active treatment and of survivors of cancer. The disciplines of cardiology and oncology have increasingly recognized the benefits to patients of collaborating in the care of cancer patients with cardiac disease. This increased recognition arises from several factors: the aging population in which both cardiac and cancer diagnoses are common; the cellular and molecular therapeutic targets of newer medical treatments, and, in particular, the specific patient treatment choices and decisions that require careful, effective clinical interactions between these 2 disciplines. Responding to this need for an effective partnership between cardiology and oncology, the International CardiOncology Society was created and has set goals to develop and enhance our understanding and management of these clinical difficulties.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Developing a cardiology-oncology clinical practice guideline.Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):173-9. doi: 10.1016/j.pcad.2010.06.001. Prog Cardiovasc Dis. 2010. PMID: 20728705 Review.
-
Cardiac disease in cancer patients: an overview.Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):80-7. doi: 10.1016/j.pcad.2010.05.004. Prog Cardiovasc Dis. 2010. PMID: 20728694 No abstract available.
-
Interventional strategies to manage heart failure in patients with cancer.Heart Fail Clin. 2011 Jul;7(3):395-402. doi: 10.1016/j.hfc.2011.03.010. Epub 2011 May 14. Heart Fail Clin. 2011. PMID: 21749891 Review.
-
Cardiac toxicity from systemic cancer therapy: a comprehensive review.Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):94-104. doi: 10.1016/j.pcad.2010.05.006. Prog Cardiovasc Dis. 2010. PMID: 20728696 Review.
-
Cardio-Oncology Programs Strive to Balance Cancer Care With Heart Health.Circulation. 2016 Jul 26;134(4):353-4. doi: 10.1161/CIRCULATIONAHA.116.024094. Circulation. 2016. PMID: 27462055 No abstract available.
Cited by
-
Metastatic malignancies and the effect on arterial stiffness and blood pressure levels: the possible role of chemotherapy.Onco Targets Ther. 2018 Oct 11;11:6785-6793. doi: 10.2147/OTT.S156318. eCollection 2018. Onco Targets Ther. 2018. PMID: 30349311 Free PMC article.
-
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.Circulation. 2018 Feb 20;137(8):e30-e66. doi: 10.1161/CIR.0000000000000556. Epub 2018 Feb 1. Circulation. 2018. PMID: 29437116 Free PMC article.
-
Risk Profiling of Cancer Treatment-Related Cardiovascular Disorders in Breast Cancer Patients Who Received Adjuvant Chemotherapy With Trastuzumab.Circ Rep. 2020 Mar 24;2(4):235-242. doi: 10.1253/circrep.CR-19-0119. Circ Rep. 2020. PMID: 33693235 Free PMC article.
-
Cardiovascular co-morbidity in cancer patients: the role of psychological distress.Cardiooncology. 2016 Nov 15;2(1):9. doi: 10.1186/s40959-016-0019-x. Cardiooncology. 2016. PMID: 33530146 Free PMC article.
-
Cardiovascular Complications of Hematopoietic Stem Cell Transplantation.Curr Treat Options Cardiovasc Med. 2016 Apr;18(4):25. doi: 10.1007/s11936-016-0447-9. Curr Treat Options Cardiovasc Med. 2016. PMID: 26909819 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical